TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT05785741: A Study of DB-1310 in Advanced/Metastatic Solid Tumors

Sponsor: DualityBio Inc. · Phase: PHASE1/PHASE2 · Area: ONCOLOGY · Target Enrollment: 1000 pts

Competing Trials Overlap

14 Active Trials

Excess Burn Exposure

$12,566,400

Rescue Site Savings

+$8,285,970

Unlock Full NCT05785741 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05785741 Rescue Dossier →